CIK 0001613103
- Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- Operating
- Phone
- +353 14381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-01 | WHITE ROBERT JOHN EVP & President MITG | Returned to the company | −2,300 | $109.37 | $252K | 51,917 |
| 2019-10-01 | WHITE ROBERT JOHN EVP & President MITG | Exercise or conversion · Stock Option (Right to Buy) | −16,817 | 0 | ||
| 2019-10-01 | WHITE ROBERT JOHN EVP & President MITG | Exercise or conversion · Stock Option (Right to Buy) | −27,353 | 9,643 | ||
| 2019-10-01 | WHITE ROBERT JOHN EVP & President MITG | Exercise or conversion · Stock Option (Right to Buy) | −7,995 | 0 | ||
| 2019-09-27 | Kuntz Richard SVP & Chief Medical & Science | Sale | −21,325 | $107.51 | $2.3M | 78,916 |
| 2019-09-27 | Kuntz Richard SVP & Chief Medical & Science | Sale | −100 | $108.21 | $11K | 78,816 |
| 2019-09-25 | Lenehan James T Director | Exercise or conversion | +1,813 | $44.13 | $80K | 55,464 |
| 2019-09-25 | Lenehan James T Director | Shares withheld for taxes | −744 | $107.62 | $80K | 54,720 |
| 2019-09-25 | Lenehan James T Director | Exercise or conversion · Stock Option (Right to Buy) | −1,813 | 0 | ||
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −10,000 | $107.09 | $1.1M | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +10,257 | $78.00 | $800K | 41,018 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −10,257 | $107.31 | $1.1M | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +321 | $78.00 | $25K | 31,082 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −321 | $107.22 | $34K | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +27,254 | $88.06 | $2.4M | 58,015 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −27,254 | $107.28 | $2.9M | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +852 | $88.06 | $75K | 31,613 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −852 | $107.22 | $91K | 30,761 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Exercise or conversion | +19,054 | $83.97 | $1.6M | 49,815 |
| 2019-09-10 | HAKAMI HOOMAN EVP & Group President Diabetes | Sale | −19,054 | $107.41 | $2.0M | 30,761 |
Page 45 of 49 · 966 trades